Jonathan Alspaugh SEC EDGAR Filings (CIK 0001868112)

SEC EDGAR filings, ownership reports, and insider transactions for Jonathan Alspaugh.

Business address
C/O Aeglea Biotherapeutics, Inc., 805 Las Cimas Parkway, Suite 100, Austin, TX, 78746
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jonathan Alspaugh has filed 9 SEC EDGAR filings since 08 Jul 2021

Latest Filings

Recent SEC filings for Jonathan Alspaugh including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Jun 2023 22 Jun 2023 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 24 Feb 2023 23 Feb 2023 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 Aug 2022 23 Aug 2022 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 15 Mar 2022 11 Mar 2022 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Feb 2022 17 Feb 2022 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Dec 2021 09 Dec 2021 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Aug 2021 16 Aug 2021 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Jul 2021 06 Jul 2021 001-37722
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 08 Jul 2021 06 Jul 2021 001-37722

About this filer

Jonathan Alspaugh files with the SEC under CIK 0001868112. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages